A sale of Life Technologies (LIFE) could be back on, with the biomedical laboratory equipment...
Wednesday, March 6, 1:43 AM ETA sale of Life Technologies (LIFE) could be back on, with the biomedical laboratory equipment maker reportedly in talks with a consortium of private-equity firms that includes Blackstone (BX) and Carlyle (CG). Last month, prospects for a sale looked dim, as potential suitors had been put off by the run up in Life's share price, which has given it a market cap of $10.6B and could still be an obstacle to a deal.
HEALTHCARE ETFs IN FOCUS
Latest Healthcare Articles